- Responsibility Statement
- Independent Auditor´s Report
- Consolidated Balance Sheet
- Consolidated Income Statement
- Consolidated Statement of Cash Flows
- Consolidated Statement of Recognized Income and Expense
- Notes
- Statement of Movements of Intangible and Tangible Assets and Financial Assets
- Shareholdings
| Financial Expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| € in millions |
|
Year ending Dec. 31 |
||
| 2007 |
2006 | |
| Interest expense on financial instruments measured at amortized cost |
(163) | (182) |
| Interest expense on financial instruments at fair value through profit or loss | (1) | (1) |
| Interest expense on provisions and non-financial liabilities | (2) | (1) |
| Net foreign exchange losses |
— |
— |
| Other | (4) | (13) |
| Financial expenses | (170) | (197) |
Interest income from financial instruments, measured at amortized cost, mainly consists of interest income from bank deposits and loans.
Interest income / expense from financial instruments at fair value through profit or loss mainly includes interest payments from investment funds as well as net interest payments from interest derivatives not being part of a hedging relationship. Unrealized gains / losses from fair value measurement of such financial assets are shown in other financial income or expenses.
Interest expense on financial instruments measured at amortized cost mainly includes interest on borrowings and effects from using the effective interest method.
Interest expense on provisions and non-financial liabilities particularly includes effects from measurement of provisions at present value and interest on non-financial liabilities such as tax payables.
Other financial expenses include impairment losses on other financial assets amounting to € 4 million and € 8 million for the years ending December 31, 2007 and 2006, respectively. Also included in other financial expenses are minority interests, which are not recorded in equity according to IAS 32.
Information regarding the Group’s available-for-sale investments, borrowings and financial
instruments is also included in these Notes. 
see Notes 6, 13, 15 and 23
